A guide to selecting high-performing antibodies for STING1 (Uniprot ID: Q86WV6) for use in western blot, immunoprecipitation, and immunofluorescence
F1000Research · 2025
DOI: 10.12688/f1000research.155929.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift F1000Research, 2025. Verfasst von Vera Ruíz Moleón und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Québec, H…. Hauptthemen laut MEDLINE: Membrane Proteins, Immunoprecipitation, Antibodies, Blotting, Western. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Genome Canada, Genome Quebec, Mitacs.
Abstract (Originalsprache)
Stimulator of interferon genes protein (STING1) is an immune adaptor protein which promotes innate immune defense mechanisms against pathogens. To enhance our understanding of STING1-associated disease, it is essential to make high-performing antibodies accessible to the scientific community. This study aims to improve reliability of STING1 research as we have characterized sixteen STING1 commercial antibodies for western blot, immunoprecipitation, and immunofluorescence using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. These studies are part of a larger, collaborative initiative seeking to address antibody reproducibility issues by characterizing commercially available antibodies for human proteins and publishing the results openly as a resource for the scientific community. While use of antibodies and protocols vary between laboratories, we encourage readers to use this report as a guide to select the most appropriate antibodies for their specific needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Québec, H3A 2B4, Canada.
ORCID-Profile: Vera Ruíz Moleón, Charles Alende, Kathleen Southern, Carl Laflamme
Förderung
- Genome Canada
- Genome Quebec
- Mitacs
- Michael J. Fox Foundation for Parkinson’s Disease Research
- Ontario Genomics
Zitieren
APA
Ruíz Moleón, V., Alende, C., Fotouhi, M., Ayoubi, R., Southern, K., Laflamme, C., NeuroSGC/YCharOS/EDDU collaborative group, & ABIF consortium (2025). A guide to selecting high-performing antibodies for STING1 (Uniprot ID: Q86WV6) for use in western blot, immunoprecipitation, and immunofluorescence. F1000Research. https://doi.org/10.12688/f1000research.155929.2
Vancouver
Ruíz Moleón V, Alende C, Fotouhi M, Ayoubi R, Southern K, Laflamme C, et al. A guide to selecting high-performing antibodies for STING1 (Uniprot ID: Q86WV6) for use in western blot, immunoprecipitation, and immunofluorescence. F1000Research. 2025. doi:10.12688/f1000research.155929.2
BibTeX
@article{RuzMolen2025,
author = {Ruíz Moleón, Vera and Alende, Charles and Fotouhi, Maryam and Ayoubi, Riham and Southern, Kathleen and Laflamme, Carl and NeuroSGC/YCharOS/EDDU collaborative group, NeuroSGC/YCharOS/EDDU collaborative group and ABIF consortium, ABIF consortium},
title = {A guide to selecting high-performing antibodies for STING1 (Uniprot ID: Q86WV6) for use in western blot, immunoprecipitation, and immunofluorescence},
journal = {F1000Research},
year = {2025},
doi = {10.12688/f1000research.155929.2}
}
EUVIMED